US SB1476 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on May 9 2023 - 25% progression, died in committee
Action: 2023-05-09 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 9 2023 - 25% progression, died in committee
Action: 2023-05-09 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend the Public Health Service Act to increase the transparency of pharmaceutical research costs, and for other purposes.
Title
Pharmaceutical Research Transparency Act of 2023
Sponsors
| Sen. Debbie Stabenow [D-MI] | Sen. Tina Smith [D-MN] | Sen. Peter Welch [D-VT] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-05-09 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB3160 (Same As) 2023-05-12 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/1476/all-info |
| Text | https://www.congress.gov/118/bills/s1476/BILLS-118s1476is.pdf |
